# Twin Vee PowerCats, Co.: financial statements, quarterly

VEEE · Nasdaq · CIK 1855509 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/veee.md) · [Financials](/companies/veee/financials.md) · [Filings](/companies/veee/filings.md) · [Insiders](/companies/veee/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/veee/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [8,077](/filings/0001731122-24-001808.md) | [8,445 d](/filings/0001731122-25-000412.md) | [5,276](/filings/0001731122-25-000684.md) | [4,327](/filings/0001731122-25-001086.md) | [2,901](/filings/0001731122-25-001489.md) | [1,884 d](/filings/0001731122-26-000317.md) | [3,612](/filings/0001731122-26-000687.md) | [4,756](/filings/0001731122-26-001024.md) | [3,429](/filings/0001731122-25-001489.md) | [3,022 d](/filings/0001731122-26-000317.md) | [3,965](/filings/0001731122-26-000687.md) | [3,128](/filings/0001731122-26-001024.md) |
| Cost of revenue | $k | [7,471](/filings/0001731122-24-001808.md) | [8,231 d](/filings/0001731122-25-000412.md) | [4,999](/filings/0001731122-25-000684.md) | [4,124](/filings/0001731122-25-001086.md) | [3,047](/filings/0001731122-25-001489.md) | [2,969 d](/filings/0001731122-26-000317.md) | [3,075](/filings/0001731122-26-000687.md) | [4,102](/filings/0001731122-26-001024.md) | [3,474](/filings/0001731122-25-001489.md) | [2,911 d](/filings/0001731122-26-000317.md) | [3,768](/filings/0001731122-26-000687.md) | [3,311](/filings/0001731122-26-001024.md) |
| Gross profit | $k | [606](/filings/0001731122-24-001808.md) | [214 d](/filings/0001731122-25-000412.md) | [277](/filings/0001731122-25-000684.md) | [202](/filings/0001731122-25-001086.md) | [(146)](/filings/0001731122-25-001489.md) | [(1,085) d](/filings/0001731122-26-000317.md) | [537](/filings/0001731122-26-000687.md) | [654](/filings/0001731122-26-001024.md) | [(45.2)](/filings/0001731122-25-001489.md) | [111 d](/filings/0001731122-26-000317.md) | [196](/filings/0001731122-26-000687.md) | [(183)](/filings/0001731122-26-001024.md) |
| Research and development | $k | [63.9](/filings/0001731122-24-001808.md) | [513 d](/filings/0001731122-25-000412.md) | [150](/filings/0001731122-25-000684.md) | [345](/filings/0001731122-25-001086.md) | [89.4](/filings/0001731122-25-001489.md) | [2.5 d](/filings/0001731122-26-000317.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | [985](/filings/0001731122-24-001808.md) | [813 d](/filings/0001731122-25-000412.md) | [694](/filings/0001731122-25-000684.md) | [756](/filings/0001731122-25-001086.md) | [765](/filings/0001731122-25-001489.md) | [881 d](/filings/0001731122-26-000317.md) | [599](/filings/0001731122-26-000687.md) | [605](/filings/0001731122-26-001024.md) | [651](/filings/0001731122-25-001489.md) | [648 d](/filings/0001731122-26-000317.md) | [861](/filings/0001731122-26-000687.md) | [600](/filings/0001731122-26-001024.md) |
| Operating income | $k | [(2,779)](/filings/0001731122-24-001808.md) | [(3,794) d](/filings/0001731122-25-000412.md) | [(2,543)](/filings/0001731122-25-000684.md) | [(4,659)](/filings/0001731122-25-001086.md) | [(3,112)](/filings/0001731122-25-001489.md) | [(4,238) d](/filings/0001731122-26-000317.md) | [(1,679)](/filings/0001731122-26-000687.md) | [(1,676)](/filings/0001731122-26-001024.md) | [(2,777)](/filings/0001731122-25-001489.md) | [(2,650) d](/filings/0001731122-26-001024.md) | [(2,136)](/filings/0001731122-26-000687.md) | [(3,022)](/filings/0001731122-26-001024.md) |
| Interest expense | $k | [0.0](/filings/0001731122-24-001808.md) | not reported | [67.0](/filings/0001731122-25-000684.md) | [54.9](/filings/0001731122-25-001086.md) | [57.0](/filings/0001731122-25-001489.md) | not reported | [36.2](/filings/0001731122-26-000687.md) | [19.6](/filings/0001731122-26-001024.md) | [12.6](/filings/0001731122-25-001489.md) | not reported | [10.9](/filings/0001731122-26-000687.md) | [8.9](/filings/0001731122-26-001024.md) |
| Income tax | $k | [0.0](/filings/0001731122-24-001808.md) | not reported | [0.0](/filings/0001731122-24-000812.md) | [0.0](/filings/0001731122-24-001254.md) | [0.0](/filings/0001731122-24-001808.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,862)](/filings/0001731122-24-001808.md) | [(2,829) d](/filings/0001731122-25-000412.md) | [(2,335)](/filings/0001731122-25-001489.md) | [(4,519)](/filings/0001731122-25-001489.md) | [(3,010)](/filings/0001731122-25-001489.md) | [(3,902) d](/filings/0001731122-26-000317.md) | [(1,610)](/filings/0001731122-26-000687.md) | [(1,654)](/filings/0001731122-25-001489.md) | [(2,756)](/filings/0001731122-25-001489.md) | [(2,587) d](/filings/0001731122-26-000317.md) | [(2,094)](/filings/0001731122-26-000687.md) | [(2,898)](/filings/0001731122-26-001024.md) |
| Diluted EPS | $ per share | [(0.20)](/filings/0001731122-24-001808.md) | not reported | [(1.77)](/filings/0001731122-25-000684.md) | [(3.09)](/filings/0001731122-25-001086.md) | [(2.64)](/filings/0001731122-25-001489.md) | not reported | [(40.05)](/filings/0001731122-26-000687.md) | [(32.22)](/filings/0001731122-26-001024.md) | [(1.23)](/filings/0001731122-25-001489.md) | not reported | [(12.93)](/filings/0001731122-26-000687.md) | [(5.07)](/filings/0001731122-26-001024.md) |
| Basic EPS | $ per share | [(0.20)](/filings/0001731122-24-001808.md) | not reported | [(1.77)](/filings/0001731122-25-000684.md) | [(3.09)](/filings/0001731122-25-001086.md) | [(2.64)](/filings/0001731122-25-001489.md) | not reported | [(40.05)](/filings/0001731122-26-000687.md) | [(32.22)](/filings/0001731122-26-001024.md) | [(1.23)](/filings/0001731122-25-001489.md) | not reported | [(12.93)](/filings/0001731122-26-000687.md) | [(5.07)](/filings/0001731122-26-001024.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.1](/filings/0001731122-24-001808.md) | [16.5](/filings/0001731122-25-000412.md) | [16.1](/filings/0001731122-24-000812.md) | [13.9](/filings/0001731122-24-001254.md) | [11.1](/filings/0001731122-24-001808.md) | [7.5](/filings/0001731122-26-000317.md) | [5.1](/filings/0001731122-25-000684.md) | [6.2](/filings/0001731122-25-001086.md) | [2.9](/filings/0001731122-25-001489.md) | [1.4](/filings/0001731122-26-000317.md) | [5.7](/filings/0001731122-26-000687.md) | [3.9](/filings/0001731122-26-001024.md) |
| Current assets | $m | [32.7](/filings/0001731122-23-002122.md) | [26.6](/filings/0001731122-25-000412.md) | [21.8](/filings/0001731122-24-000812.md) | [19.6](/filings/0001731122-24-001254.md) | [15.4](/filings/0001731122-24-001808.md) | [10.4](/filings/0001731122-26-000317.md) | [12.2](/filings/0001731122-25-000684.md) | [13.4](/filings/0001731122-25-001086.md) | [10.1](/filings/0001731122-25-001489.md) | [4.9](/filings/0001731122-26-001024.md) | [9.6](/filings/0001731122-26-000687.md) | [8.6](/filings/0001731122-26-001024.md) |
| Total assets | $m | [44.3](/filings/0001731122-23-002122.md) | [39.8](/filings/0001731122-25-000412.md) | [36.5](/filings/0001731122-24-000812.md) | [33.8](/filings/0001731122-24-001254.md) | [30.1](/filings/0001731122-24-001808.md) | [25.9](/filings/0001731122-26-000317.md) | [23.6](/filings/0001731122-25-000684.md) | [22.4](/filings/0001731122-25-001086.md) | [18.9](/filings/0001731122-25-001489.md) | [16.2](/filings/0001731122-26-001024.md) | [23.2](/filings/0001731122-26-000687.md) | [20.7](/filings/0001731122-26-001024.md) |
| Current liabilities | $m | [5.3](/filings/0001731122-23-002122.md) | [4.2](/filings/0001731122-25-000412.md) | [2.9](/filings/0001731122-24-000812.md) | [4.6](/filings/0001731122-24-001254.md) | [3.8](/filings/0001731122-24-001808.md) | [3.7](/filings/0001731122-26-000317.md) | [3.0](/filings/0001731122-25-000684.md) | [3.2](/filings/0001731122-25-001086.md) | [2.4](/filings/0001731122-25-001489.md) | [2.2](/filings/0001731122-26-001024.md) | [3.2](/filings/0001731122-26-000687.md) | [3.6](/filings/0001731122-26-001024.md) |
| Total liabilities | $m | [9.1](/filings/0001731122-23-002122.md) | [7.8](/filings/0001731122-25-000412.md) | [6.3](/filings/0001731122-24-000812.md) | [7.8](/filings/0001731122-24-001254.md) | [6.9](/filings/0001731122-24-001808.md) | [6.7](/filings/0001731122-26-000317.md) | [5.9](/filings/0001731122-25-000684.md) | [3.7](/filings/0001731122-25-001086.md) | [3.0](/filings/0001731122-25-001489.md) | [2.8](/filings/0001731122-26-001024.md) | [6.0](/filings/0001731122-26-000687.md) | [6.2](/filings/0001731122-26-001024.md) |
| Long-term debt | $m | [0.5](/filings/0001731122-23-002122.md) | [0.5](/filings/0001731122-24-000500.md) | [0.5](/filings/0001731122-24-000812.md) | [0.5](/filings/0001731122-24-001254.md) | [0.5](/filings/0001731122-24-001808.md) | [0.5](/filings/0001731122-25-000412.md) | [0.5](/filings/0001731122-25-000684.md) | [0.5](/filings/0001731122-25-001086.md) | [0.5](/filings/0001731122-25-001489.md) | [0.5](/filings/0001731122-26-000317.md) | [0.5](/filings/0001731122-26-000687.md) | [0.5](/filings/0001731122-26-001024.md) |
| Shareholders' equity | $m | [25.9](/filings/0001731122-23-002122.md) | [23.5](/filings/0001731122-25-000412.md) | [22.3](/filings/0001731122-24-000812.md) | [19.6](/filings/0001731122-24-001254.md) | [17.4](/filings/0001731122-24-001808.md) | [19.2](/filings/0001731122-26-001024.md) | [17.7](/filings/0001731122-26-001024.md) | [18.6](/filings/0001731122-26-001024.md) | [15.9](/filings/0001731122-25-001489.md) | [13.5](/filings/0001731122-26-001024.md) | [17.2](/filings/0001731122-26-001024.md) | [14.4](/filings/0001731122-26-001024.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,500) d](/filings/0001731122-24-001808.md) | [(4.6) d](/filings/0001731122-25-000412.md) | [(1,750)](/filings/0001731122-25-000684.md) | [(482) d](/filings/0001731122-25-001086.md) | [(2,407) d](/filings/0001731122-25-001489.md) | [(2,335) d](/filings/0001731122-26-000317.md) | [(1,736)](/filings/0001731122-26-000687.md) | [(746) d](/filings/0001731122-26-001024.md) | [(2,648) d](/filings/0001731122-25-001489.md) | [(1,749) d](/filings/0001731122-26-000317.md) | [(1,661)](/filings/0001731122-26-000687.md) | [(1,610) d](/filings/0001731122-26-001024.md) |
| Capital expenditure | $k | [789 d](/filings/0001731122-24-001808.md) | [2,749 d](/filings/0001731122-25-000412.md) | [1,991](/filings/0001731122-25-000684.md) | [1,724 d](/filings/0001731122-25-001086.md) | [1,329 d](/filings/0001731122-25-001489.md) | [1,297 d](/filings/0001731122-26-000317.md) | [829](/filings/0001731122-26-000687.md) | [708 d](/filings/0001731122-26-001024.md) | [480 d](/filings/0001731122-25-001489.md) | [140 d](/filings/0001731122-26-000317.md) | [109](/filings/0001731122-26-000687.md) | [127 d](/filings/0001731122-26-001024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,000](/filings/0001731122-23-001492.md) | [9,520](/filings/0001731122-24-000812.md) | [9,520](/filings/0001731122-24-001254.md) | [9,520](/filings/0001731122-24-001808.md) | [952](/filings/0001731122-25-000684.md) | [952](/filings/0001731122-25-001086.md) | [952](/filings/0001731122-25-001489.md) | [40.2](/filings/0001731122-26-000687.md) | [51.3](/filings/0001731122-26-001024.md) | [2,237](/filings/0001731122-25-001489.md) | [162](/filings/0001731122-26-000687.md) | [571](/filings/0001731122-26-001024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 574,502 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001731122-26-001024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.